Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-03-11 | 2026-03-09 | XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Off | M - OptEx | — | +7,500 | 7,500 | New | — |
| DT | 2026-03-11 | 2026-03-10 | XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Off | S - Sale+OE | $60.11 | -2,771 | 4,729 | -37% | -$166.6K |
| DT | 2026-03-11 | 2026-03-09 | XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Off | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
| DT | 2026-03-11 | 2026-03-09 | XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Off | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-03-09 | M | A | 7,500 | — | 7,500 | D | — | — | (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination. |
| 2 | Common | Common Shares | 2026-03-10 | S | D | 2,771 | $60.11 | 4,729 | D | — | — | |
| 3 | Derivative | Performance Share Units | 2026-03-09 | M | D | 7,500 | $0.00 | 0 | D | — · — to — | 7,500 Common Shares | (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination. |
| 4 | Derivative | Performance Share Units | 2026-03-09 | A | A | 7,500 | $0.00 | 7,500 | D | — · — to — | 7,500 Common Shares | (F1) Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination. |